CLS1 — McKesson Europe AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareConservativeLarge Cap
- €4.96bn
- €4.69bn
- €9.26bn
Annual cashflow statement for McKesson Europe AG, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -299 | -52 | -66.1 | 0.9 | -49.5 |
| Depreciation | |||||
| Non-Cash Items | 33.9 | 56 | 75.2 | -1.5 | -163 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 99.1 | 189 | 1 | 78.5 | 53.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 266 | 345 | 313 | 363 | 0.9 |
| Capital Expenditures | -128 | -148 | -128 | -100 | -28.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 244 | -22.8 | -66.1 | 279 | 721 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 117 | -171 | -194 | 178 | 692 |
| Financing Cash Flow Items | 19.7 | 257 | 111 | 81.4 | 632 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -57.2 | -143 | 26.3 | -328 | 48.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 320 | 30.4 | 150 | 215 | 742 |